James Panek
Direttore/Membro del Consiglio presso SUTRO BIOPHARMA, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
James P.
Panek is an Independent Director at Sutro Biopharma, Inc. and the Chief Operating Officer at CHO Plus, Inc. He previously served as the Chairman & Co-Chief Executive Officer at Celltrion, Inc. from 2002 to 2006.
From 2007 to 2011, he was the President, Chief Executive Officer, CFO & Director at Diadexus, Inc. Prior to that, he held the positions of President, Chief Financial Officer, CAO & Director at VaxGen, Inc. from 2002 to 2010.
He also served as a Director at diaDexus, Inc. and held the role of Senior Vice President-Product Operations at Genentech, Inc. from 1982 to 2001.
Mr. Panek completed his undergraduate and graduate degrees at the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC.
-.--% | 06/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di James Panek
| Società | Posizione | Inizio |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Direttore/Membro del Consiglio | 07/01/2020 |
| Cho Plus, Inc. | Direttore operativo | - |
Precedenti posizioni note di James Panek
| Società | Posizione | Fine |
|---|---|---|
| DIADEXUS, INC. | Amministratore Delegato | 01/01/2011 |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Direttore/Membro del Consiglio | 01/11/2010 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Direttore Finanziario/CFO | 01/01/2010 |
| CELLTRION, INC. | Amministratore Delegato | 01/01/2006 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2001 |
Formazione di James Panek
| University of Michigan | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| CELLTRION, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Cho Plus, Inc. |
- Borsa valori
- Insiders
- James Panek
